|
Mitch Gillingwater -
December 30, 2019 |
|
|
|
|
Muaz Nasir -
March 26, 2019 |
Great overview of potential options to be considered. Any approach, whether universal or combination public/private, should factor in bringing down the costs of medications across the board through bulk purchasing.
|
|
|
|
Paul Henricks -
November 2, 2018 |
| Much is being discussed about National Pharmacare and while many support the notion, few understand the specifics and implications of potential changes to our current pharmaceutical framework. This provides an excellent overview of potential "National Pharmacare" options. It falls short of making specific recommendations, while making qualitative and not quantitative comparisons of their impact. |
|
|